(Q34443368)

2 August 2017

1 reference

title

Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis (English)

1 reference

2 August 2017

0 references

1 reference

S Kanji

1

1 reference

2 August 2017

J W Devlin

series ordinal

2

1 reference

2 August 2017

K A Piekos

series ordinal

3

1 reference

2 August 2017

E Racine

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

1389-1402

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Sepsis: a new hypothesis for pathogenesis of the disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Coagulation inhibitors in sepsis and disseminated intravascular coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Immunological therapy in sepsis: currently available

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Immunological therapy of sepsis: experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Molecular basis of host-pathogen interaction in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Activation of coagulation after administration of tumor necrosis factor to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

21 January 2018

The protein C pathway

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Cell mediated events that control blood coagulation and vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Epidemic meningococcemia and purpura fulminans with induced protein C deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Best practices in the development of clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

Relation between dicrotic notch and mean pulmonary artery pressure studied by using a Swan-Ganz catheter in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1389.34417

10.1592/PHCO.21.17.1389.34417

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference